Chirogate is a US FDA-inspected prostaglandin manufacturer operating more than 10 dedicated cGMP-compliant production lines, holding several process patents worldwide that support a commercially advanced synthetic approach and a range of intermediates for new prostaglandin entities. The company has filed US DMFs for unoprostone isopropyl, treprostinil, treprostinil sodium, latanoprost, bimatoprost, carboprost tromethamine, tafluprost and travoprost, with additional registration experience in China, Japan, Canada, Australia, New Zealand and major EU countries, and a product range including treprostinil, treprostinil diethanolamine, beraprost sodium, iloprost, isomer-free latanoprost, latanoprostene bunod, misoprostol, lubiprostone, dinoprost and alprostadil.

No comments available.
Leave your rating & comment